Results 171 to 180 of about 15,262 (256)
Artificial Intelligence in Exams by Image: Ethical Pros and Cons. [PDF]
Zachini C, Nunes S, Rego F, Nunes R.
europepmc +1 more source
Characterizing industry payments for FDA-approved AI medical devices. [PDF]
Bergman A, Patel TA, Shah KP.
europepmc +1 more source
Involuntary Clozapine Treatment: A Systematic Review
ABSTRACT Introduction We aimed to synthesize the information relevant for clinical practice on involuntary clozapine treatment. Methods Articles were identified with MEDLINE, Web of Sciences and PsycINFO search from inception through September 2025 (PROSPERO database registration CRD420251234475).
Hélène Verdoux +2 more
wiley +1 more source
How to bring generative AI to oncology practice. [PDF]
Truhn D, Kather JN.
europepmc +1 more source
Graphical representation of formation of self‐assembled PEGylated Chitosan Nanoparticles and their mechanism in tumor localization. ABSTRACT Polymer‐based nanocarriers have emerged as transformative platforms in cancer nanomedicine, enabling controlled and site‐specific delivery of therapeutic agents.
Prashant Kesharwani +5 more
wiley +1 more source
Clinical Safety of Gadoxetate Disodium: Insights From 20 Years of Use and More Than 12 Million Administrations. [PDF]
Endrikat J +5 more
europepmc +1 more source
ABSTRACT This study investigated how Japanese physicians make decisions about prescribing medications during pregnancy, based on safety information provided in drug package inserts. An online questionnaire survey targeted physicians working at pregnancy hub hospitals with expertise in drug treatment during pregnancy and physicians in general hospitals ...
Mikako Goto +2 more
wiley +1 more source
Scoping review of regulatory transparency in AI-based radiology software: analysis of PMDA-approved SaMD products. [PDF]
Kikuchi T +10 more
europepmc +1 more source
In this population‐based cohort study of 2837 rituximab‐treated relapsing–remitting multiple sclerosis (RRMS) patients, 563 (20%) experienced progression independent of relapse activity (PIRA) over 6 years. No pre‐specified comorbidities predicted PIRA and only neuromuscular bladder dysfunction (N31) reached significance among all ICD‐10 codes. Machine
Peter Alping +3 more
wiley +1 more source
Current patient attitudes to artificial intelligence applications in radiology. [PDF]
Maclean RH +7 more
europepmc +1 more source

